Prot# 6002-US-013: A 12-Wk, Double-Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter, Fixed Dose Study to Evaluate the Efficacy & Safety of a 20mg/d Oral Dose of KW-6002(Istradefylline)as Treatment for Parkinson's Disease in Patients w/Mo
- Melen, Onur (Co-PD/PI)
- Simuni, Tatyana (PD/PI)
Project: Research project